Intratympanic Steroid Use for Sudden Sensorineural Hearing Loss: Current Otolaryngology Practice

Abstract

There is a wide variation in practice with regards to ITS for SSNHL hearing loss in the United Kingdom, United States, and continental Europe. In the absence of protocols or definitive guidance from published literature, knowledge of contemporary practice may help guide or encourage reevaluation of clinical practice and will help guide the design of future clinical trials.